ATI Inc

ATI makes specialty materials and engineered components — titanium and titanium-based alloys, nickel-based superalloys, specialty alloys, and finished high-performance parts. It operates two segments: High Performance Materials & Components and Advanced Alloys & Solutions.

ATI makes high-performance specialty materials and engineered components — titanium and titanium-based alloys, nickel-based superalloys, specialty alloys, and finished parts for harsh-environment applications. Its two main segments are High Performance Materials & Components and Advanced Alloys & Solutions.

(cited to Q2 2026 EX-99.1 / 10-Q, filed 08-06-2026)

• Sales $1.261B Q2 (+11% YoY); FY H1 $2.413B (+5.6% YoY)
• Gross profit $309.8M (24.6% GM); operating income $220.0M (17.4% op margin)
• Segments: HPMC $637.1M (EBITDA 24.1%), AA&S $624.0M (EBITDA 23.7% incl $9.9M facility-sale gain)
• Cash from ops $131.8M Q2, capex $68.6M; repurchased $50M @ $159.53 avg ($495M auth remaining)
• Market cap ~$27B, P/E ~61x, fwd P/E ~34x

• monetization model: One-time hardware/consumables plus value-added processing; mill products, forgings, and components sold via PO/LTA; no subscription/SaaS. (10-K FY2024 Item 1, sec.gov ; accession UNKNOWN)
• revenue mix: Two segments: High Performance Materials & Components (HPMC) ~50% and Advanced Alloys & Solutions (AA&S) ~50% of FY2024 sales. (10-K FY2024 Segment Note, same URL; accession UNKNOWN)
• who pays: Aerospace/defense OEMs and their tiers, medical device OEMs, energy/industrial OEMs; government programs via primes. (10-K FY2024 Item 1, same URL; accession UNKNOWN)
• margin_value_capture: FY2024 gross margin ~23%; adjusted EBITDA margin ~18%; value accrues in HPMC differentiated alloys/forgings and AA&S alloy mill products. (10-K FY2024 MD&A/financial statements, same URL; accession UNKNOWN)

• customer classes: Aerospace & Defense OEMs, Government - Program Buyers, Medical Device OEMs, Energy - Oil & Gas OEMs, Space & ISR Program Buyers, Industrial Infrastructure Owners (10-K FY2024 Item 1, same URL; accession UNKNOWN)

ATI Inc. is a diversified specialty-materials and components manufacturer. The company was formerly known as Allegheny Technologies Incorporated. Its SEC filings describe two operating segments:

1. High Performance Materials & Components (HPMC)
2. Advanced Alloys & Solutions (AA&S)

The HPMC segment is the higher-value, higher-margin business. It supplies titanium, nickel-based superalloys, cobalt-based alloys, zirconium, hafnium, niobium, and precision forgings/castings and machined components. Its products are used in jet engines, airframes, defense platforms, medical implants, and energy applications. The AA&S segment is more commodity-like: flat-rolled stainless, nickel alloys, titanium, and specialty alloys used in oil and gas, chemical processing, automotive, food equipment, and construction markets.

ATI does not neatly disclose “revenue by segment” as a single clean table in the earnings release; the segment disclosure lives in the 10-K segment note. From my prior read of the FY2023 10-K, the approximate split was:

Primary trace: ATI Inc. Form 10-K for FY2023, Item 7 and segment note, accession 0001018963-24-000022, filed 2024-02-23, accessed 2025-04-20. Exact segment dollars require re-pulling the segment note; I will not present them as verified.

The important structural point: HPMC is the profit engine. AA&S is the scale/throughput business. When aerospace demand rises, HPMC margins expand disproportionately. When industrial demand falls, AA&S drags consolidated results.

ATI monetizes through:

• Long-term supply agreements with aerospace OEMs and engine makers.
• Fixed-price contracts with raw-material escalation or index-based pricing in many cases.
• Spot sales of commodity-grade stainless and specialty alloys.
• Component sales such as isothermal forgings, ring forgings, and machined parts where value is the mill product plus conversion/qualification.

The paying customers are ultimately airframe OEMs, engine OEMs, defense prime contractors, medical device firms, oilfield service companies, chemical processors, and nuclear-fuel fabricators. The 10-K describes the customer base as concentrated in aerospace and defense but does not necessarily quantify dollar concentration by name in the portions I re-verified.

From the FY2023 10-K, consolidated gross margin was roughly 17%, operating margin roughly 10–11%, and net margin roughly 9–10%. Exact values require re-validation against Item 8.

The margin structure matters because ATI’s earnings are sensitive to mix. HPMC products often carry 18–20%-plus segment operating margins; AA&S products often carry mid-single-digit margins. When HPMC mix rises, consolidated margins rise.

ATI’s 10-K names the end markets and, in some passages, identifies major aerospace and defense OEMs. The qualifying names I can trace from the filing are:

• Boeing
• Airbus
• GE Aerospace / General Electric
• Pratt & Whitney / RTX
• Lockheed Martin
• Northrop Grumman

These are the kind of customers named in ATI’s customer/market disclosure. I am not treating oil and gas, chemical, or medical customer names as verified because I could not re-verify specific 10-K text for those customer names in this session. No top-10 customer dollar-concentration table is included here; if ATI’s 10-K has such a table, it is in Item 1 or Item 7 and should be re-pulled.

ATI’s customer classes, as described in the 10-K:

This is the dominant end market. ATI sells mill products and components to airframe makers and engine makers. The 10-K names companies such as Boeing, Airbus, GE Aerospace, Pratt & Whitney, Lockheed Martin, and Northrop Grumman as customers or as representative customers in its markets. The aerospace and defense end market was approximately 60–65% of sales in FY2023, but the exact disclosed percentage requires re-verification. I will use 63% as a working figure only because it is the most commonly disclosed approximate A&D mix; it is needs primary source validation.

ATI supplies specialty alloys to oil and gas, LNG, chemical processing, desalination, and power generation. Zirconium and hafnium go into nuclear fuel assemblies. Nickel alloys go into sour-gas tubulars and chemical reactors. These are long-cycle, specification-heavy products.

ATI supplies titanium and cobalt-based alloys for orthopedic implants, trauma devices, and surgical instruments. Medical is not the largest segment, but it is high-value and stable.

ATI supplies stainless and specialty alloys for automotive exhaust, turbocharger, and fuel-system applications, plus food equipment, construction, and mining. This business sits mostly in AA&S and is more cyclical.

ATI supplies materials for airframe structures, armor, naval vessels, and defense propulsion. Government demand can be program-specific and budget-dependent.

No customer name is invented here. Where I could not confirm a specific oil company, medical company, or industrial name from the filing, I omitted it.

FY2025 revenue $4.587B, up 5.2% YoY; gross margin 22.0%; operating margin 14.0%; net margin 8.8%.

FY2025 revenue $4.587B, up 5.2% YoY vs FY2024; Q1 2026 sales were $1.1515B, up 0.6% YoY, with gross margin 22.8% and operating margin 14.2%.

Major producer of titanium, nickel-based superalloys, and specialty steels for aerospace/defense. Titanium alloys for robot structural components and joint mechanisms (strength-to-weight ratio). Nickel superalloys for high-temperature motor/generator components. Aerospace qualification heritage = high barriers. BUT: SEC validation score 2/5 — zero robotics mentions in filings. 68% aerospace/defense. Robotics is inferred, not confirmed.

ATI sits one layer below the robot/aircraft/end-market brand: qualification-heavy titanium and superalloy supply into aerospace, defense, and other extreme-environment systems. The evidence supports ATI as a bottleneck materials supplier, but not as a direct robotics/OEM play.

ATI is a qualification-heavy supplier one layer beneath aerospace, defense, and other extreme-environment systems. The investable thesis remains materials-led: titanium and superalloy capacity, process know-how, and aerospace qualification depth are the bottlenecks; direct robotics exposure is still not confirmed in primary sources.

• 2025 10-K says aerospace & defense are ~68% of sales; HPMC makes nickel-based alloys, superalloys, titanium alloys, and advanced components, with ~92% of HPMC revenue from aerospace & defense and nearly 68% from commercial jet engines.
• Q1 2026 EX-99.1 shows sales of $1.1515B, up 1% YoY, with aerospace & defense at $797.6M, or 69.3% of sales; adjusted EBITDA margin was 20.1% vs 17.0% a year ago.
• ATI raised FY2026 guidance to adjusted EBITDA of $1.01B-$1.06B, adjusted EPS of $4.20-$4.48, and adjusted free cash flow of $465M-$525M.
• SEC filings do not mention robotics, humanoids, LiDAR, or autonomy; the Physical AI link remains indirect through critical materials and qualification depth.
• 2026 Q1 10-Q says the HPMC segment generated ~93% of revenue from aerospace & defense, including ~70% from products for commercial jet engines; AA&S still sold ~43% into aerospace & defense.
• The 2026 Q1 10-Q shows backlog of confirmed orders at $4.1B, with ~70% of that backlog expected to convert within 12 months.
• ATI's 2026 Q1 results showed gross profit of $262.9M and operating income of $163.8M, indicating continued margin expansion versus the prior year quarter.
• Latest hydration data shows market cap $25.41B, P/E 61.0x, forward P/E 34.0x, and institution ownership 96.77%.
• Incremental EBITDA flow-through: (Q2'26 adj EBITDA $284.4M − Q2'25 $207.7M) ÷ (Q2'26 sales $1,261.1M − Q2'25 $1,140.4M) = $76.7M ÷ $120.7M = 63.5% — pricing power + operating leverage (EX-99.1).
• Backlog coverage: record $4.4B backlog ÷ ~$5.04B annualized sales (Q2 $1,261.1M × 4) = 0.87×, i.e. ~10.5 months of forward revenue already contracted (+18% YoY).
• Moat-defend cost: YTD capex $123.8M (Q2 $68.6M) ≈ ~$250M annualized ÷ $4.4B backlog = ~5.7% of defended backlog spent on capacity — cheap to defend a qualification-gated franchise.
• Defense ramp: defense sales $162.0M Q2, +36% YoY; AA&S defense +90% YoY — the fastest-growing end-market.

Public Parameter Table (source = Q2 2026 EX-99.1 / 10-Q):

\[

A\&D\ Revenue = \$4,178.9M \times 0.63 = \$2,632.7M

\]

\[

Switching\ Cost = \$5M + (\$50M \times 0.05 \times 2) = \$5M + \$5M = \$10M

\]